analyzing-anti-trust-risk

name	analyzing-anti-trust-risk
language	en
description	Evaluates competition law exposure with market definition, HHI analysis, and remedy estimation for proposed transactions. Use when assessing merger clearance risk, analyzing market concentration, or preparing HSR filings.
tags	["analysis","mergers-and-acquisitions","risk"]
metadata	{"author":"casemark","practice_areas":["M&A Advisory","Corporate Development","Investment Banking"],"document_types":["Analysis Report"],"skill_modes":["Analysis"]}

Analyzing Anti Trust Risk

Evaluates competition law exposure with market definition, HHI analysis, and remedy estimation for proposed transactions.

When To Use

• Assessing merger or acquisition clearance risk before signing or announcement
• Preparing or reviewing HSR (Hart-Scott-Rodino) filing strategy and timing
• Evaluating whether a bolt-on acquisition triggers size-of-transaction or size-of-person thresholds [VERIFY: current HSR thresholds adjust annually]
• Analyzing market concentration impact for board presentations or investment committee memos
• Screening a target portfolio for divestitures likely required as merger remedies
• Supporting second-request preparation or response strategy

Inputs To Gather

• Transaction details: deal structure (stock vs. asset), purchase price, combined entity post-close
• Party financials: total assets and annual net sales for both buyer and target (for HSR threshold analysis)
• Relevant product/service markets: descriptions of overlapping business lines, substitutes, and complements
• Geographic scope: national, regional, or local market definitions as applicable
• Market share data: revenue or unit-based shares for each party and top competitors in each relevant market
• Customer and supplier concentration: key accounts, switching costs, and contractual lock-in periods
• Prior agency interactions: any previous DOJ/FTC investigations, consent decrees, or clearance history involving either party
• Comparable transactions: recent deals in the same sector and their regulatory outcomes

Workflow

1. Determine HSR applicability

   • Calculate size-of-transaction and size-of-person tests against current thresholds [VERIFY: thresholds update each February]
   • Identify whether any exemptions apply (e.g., acquisitions of non-voting securities, certain real estate transactions)
   • Flag if foreign antitrust filings are also required (EU merger regulation, CMA, SAMR, etc.) [VERIFY: jurisdiction-specific thresholds]

2. Define relevant markets

   • Identify candidate product markets using the hypothetical monopolist (SSNIP) framework
   • Delineate geographic markets based on customer purchasing patterns, transportation costs, and regulatory boundaries
   • Document alternative reasonable market definitions and note how each affects concentration metrics

3. Calculate market concentration (HHI)

   • Compute pre-merger HHI for each relevant market
   • Compute post-merger HHI and the delta (change in HHI)
   • Apply DOJ/FTC Horizontal Merger Guidelines thresholds:
     • Post-merger HHI < 1,500: unconcentrated — unlikely to raise concerns
     • Post-merger HHI 1,500–2,500: moderately concentrated — delta > 100 warrants scrutiny
     • Post-merger HHI > 2,500: highly concentrated — delta > 200 presumptively raises concerns [VERIFY: confirm current Guidelines thresholds]

4. Assess competitive effects

   • Unilateral effects: evaluate whether the merged firm could profitably raise prices due to elimination of close substitutes; assess diversion ratios where data permits
   • Coordinated effects: evaluate whether the merger increases likelihood of tacit coordination among remaining competitors (market transparency, product homogeneity, history of coordination)
   • Vertical effects: if the deal has a vertical dimension, assess foreclosure risk to rivals or customers
   • Buyer power / countervailing factors: consider whether large buyers or low barriers to entry offset concentration concerns

5. Evaluate likely remedies and timing risk

   • Identify product lines or geographies most likely to require divestiture
   • Estimate the value and operational feasibility of potential divestitures
   • Assess whether behavioral remedies (firewalls, licensing) might be accepted as alternatives
   • Project regulatory timeline: initial waiting period, likelihood of second request, estimated time to clearance or litigation

6. Assign overall risk rating

   • Low: unconcentrated markets, no significant overlap, clean filing expected
   • Moderate: moderately concentrated markets or delta in sensitive range; second request possible but clearance likely with limited remedies
   • High: highly concentrated markets with significant delta; second request expected; material divestitures or deal restructuring likely required
   • Prohibitive: agency challenge highly probable; litigation risk or deal abandonment should be modeled

Output

The deliverable should include:

• Executive summary: one-paragraph risk assessment with overall rating (Low / Moderate / High / Prohibitive)
• HSR filing analysis: threshold calculations, filing fee estimate, and timing implications
• Market-by-market concentration table: relevant market, parties' shares, pre/post HHI, delta, and risk flag
• Competitive effects narrative: concise analysis of unilateral, coordinated, and vertical theories of harm
• Remedy scenario matrix: potential divestitures or conditions mapped to affected markets, with estimated impact on deal value
• Timeline and process overview: expected regulatory milestones from filing through clearance
• Key assumptions and data gaps: explicit list of inputs assumed or unavailable, each flagged with [VERIFY] where appropriate

Quality Checks

• HHI calculations verified against stated market shares (shares should sum to approximately 100%)
• HSR threshold figures cross-referenced against the most recent annual adjustment [VERIFY]
• Market definitions are internally consistent — product and geographic boundaries align with the data used for share calculations
• Risk rating is consistent with the quantitative concentration analysis and qualitative competitive effects discussion
• Remedy estimates are grounded in precedent from comparable transactions, not speculative
• All jurisdiction-dependent figures, thresholds, and filing requirements are marked [VERIFY]
• Analysis distinguishes between confirmed data and estimates/assumptions throughout